US Healthcare Advertising Market Report by Product Type (Pharmaceuticals (Small Molecule Drugs), Biopharmaceuticals, Vaccines, Over-The-Counter (OTC) Drugs) 2024-2032

US Healthcare Advertising Market Report by Product Type (Pharmaceuticals (Small Molecule Drugs), Biopharmaceuticals, Vaccines, Over-The-Counter (OTC) Drugs) 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A723
Buy Now

US Healthcare Advertising Market:

The US healthcare advertising market size reached US$ 23.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 33.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4% during 2024-2032. The growing online direct-to-consumer advertising due to the shift in promotional activities towards digital platforms, the augmenting demand to obtain certification and bid for relevant keywords among advertisers, and increased advertising expenditure from healthcare organizations are among the key factors driving the market growth.

Report Attribute
 Key Statistics 
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023
US$ 23.5 Billion
Market Forecast in 2032
US$ 33.8 Billion
Market Growth Rate 2024-2032
4%


US Healthcare Advertising Market Analysis:

  • Major Market Drivers: According to the US healthcare advertising market outlook, the increasing marketing activities undertaken by organizations within the healthcare industry are primarily driving market growth. Moreover, the surging popularity of online display advertising and the growing adoption of multiple synchronized communication channels are also creating a positive outlook for the market.
  • Key Market Trends: With the ongoing digital transformation, healthcare companies are increasingly investing in advertising their offering through television, social media, and print ads, which is acting as a significant key trend bolstering market growth. Moreover, continual advancements in technology are enabling consumers to access relevant information about health conditions and available treatment options are positively influencing the US healthcare advertising market revenue.
  • Competitive Landscape: Some of the major market players in US healthcare advertising industry includes Johnson & Johnson Services, Inc., Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc., Eli Lilly and Company, Novartis International AG, Sanofi S.A, AstraZeneca PLC, F. Hoffmann-La Roche Ltd. (Roche), Bayer AG, and Bristol- Myers Squibb (BMS), among many others. 
  • Challenges and Opportunities: The increasing regulatory restrictions, growing privacy concerns, rising cost of advertising, and consumer skepticism regarding advertising claims are some of the prominent challenges faced by the market players. However, the shift to digital platforms presents new opportunities for healthcare advertisers to reach consumers more effectively and efficiently. Social media, search engine marketing, and targeted online advertising allow for precise audience targeting and personalized messaging.


US Healthcare Advertising Market Trends:

Increasing Adoption of Patient-Centered Care and Consumer Empowerment

The growing emphasis on patient-centered care and consumer empowerment is positively influencing the US Healthcare advertising market share. Healthcare organizations are increasingly focusing on attracting and engaging patients through advertising investment. Moreover, the escalating adoption of various innovative advertising strategies by healthcare providers, including showcasing testimonials and success stories of the patients and communicating personalized approaches, are also driving the US healthcare advertising market growth. Furthermore, these initiatives assist in building meaningful connections with the target audience. For instance, according to the United States Government Accountability Office, from 2016 through 2018, drug manufacturers in the US spent US$ 17.8 Billion on direct-to-consumer advertising (DTCA) for 553 drugs. Moreover, nearly half of the spending was for three therapeutic categories of drugs used in the treatment of chronic medical conditions, such as arthritis, diabetes, and depression. Such massive investments in healthcare advertisements are projected to propel the growth of the market in the coming years.

Rise Of Digital Platforms and Advancements in Technology

Ongoing advancements in advertising technology and the rising adoption of digital platforms are significantly transforming healthcare advertising. Growing penetration of social media and online search platforms backed by the widespread usage of smartphones is bolstering the US healthcare advertising market revenue. For instance, the number of people using social media in the US is expected to grow between 2024 and 2029 by 22 million. In addition to this, according to the survey conducted by Pew Research in 2023, nearly 8 in 10 US adults report using video-based platforms. Furthermore, the growth of telehealth services presents new opportunities for healthcare advertisers to promote virtual consultations, remote monitoring, and digital health solutions. Digital platforms serve as a key channel for advertising telehealth services, reaching consumers who prefer the convenience and accessibility of online healthcare. For instance, according to the National Center for Health Statistics, in 2021, 37% of US adults used telemedicine.

 

 
 

 

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

US Healthcare Advertising Market Segmentation

IMARC Group provides an analysis of the key trends in each segment of the US healthcare advertising market report, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on product type.

Breakup by Product Type:

 

 
 

 

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Pharmaceuticals (Small Molecule Drugs)
  • Biopharmaceuticals
  • Vaccines
  • Over-the-Counter (OTC) Drugs
     

Pharmaceuticals (small molecule drugs) represent the most widely used product type

The report has provided a detailed breakup and analysis of the market based on the product type. This includes pharmaceuticals (small molecule drugs), biopharmaceuticals, vaccines and over-the-counter drugs. According to the report, pharmaceuticals (small molecule drugs) represented the largest segment.

According to the US healthcare advertising market opportunities, the rising prevalence of chronic illnesses such as cardiovascular conditions, respiratory diseases, and diabetes are augmenting the demand for pharmaceuticals in the market. Moreover, the growing research and development activities in the pharmaceutical industries and growing advertising campaigns to promote the new drugs are also positively influencing the US healthcare advertising market share. In 2021, Pfizer Inc., invested US$ 13,829 Million in R&D, an increase of US$ 4.4 Billion as compared to 2020. Moreover, Johnson & Johnson also invested US$ 14.7 Billion in research and development in 2021, recording an increase of 21% as compared to 2020.

Competitive Landscape:

The top players in the US healthcare advertising market are focusing on digital marketing and technological advancements to reach a wider audience. They are leveraging online channels, social media platforms, and targeted digital advertising campaigns to expand their consumer base and drive product sales. Additionally, they are emphasizing data-driven marketing approaches, utilizing analytics and customer insights to deliver personalized and relevant advertising messages to healthcare professionals and patients. Besides this, the major companies are investing in strategic partnerships and collaborations with pharmaceutical companies, healthcare providers, and digital agencies to enhance their service offerings and access new markets. Additionally, the key players are adopting emerging trends such as mobile advertising, artificial intelligence, and virtual reality to stay ahead of the competition and provide cutting-edge advertising solutions.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Johnson & Johnson Services, Inc.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline plc.
  • Eli Lilly and Company
  • Novartis International AG
  • Sanofi S.A
  • AstraZeneca PLC
  • F. Hoffmann-La Roche Ltd. (Roche)
  • Bayer AG
  • Bristol- Myers Squibb (BMS)
     

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

US Healthcare Advertising Market News:

  • November 2023: CrowdPharm, a full-service healthcare advertising company, and its partner consultancy Hot Iron Health, were acquired by AcceSpectrum Science, an independent, integrated healthcare and scientific marketing, communications, and media firm that focuses on the pharmaceutical, biotech, and broader life science industries.
  • October 2023: Accenture acquired ConcentricLife, one of the leading healthcare marketing agencies with proficiency in helping life sciences brands. This acquisition reinforces Accenture Song’s continued investment in creating end-to-end solutions for its Life Sciences clients through relevant communications and experiences attuned to the ever-evolving lives of today’s patients and healthcare professionals.


US Healthcare Advertising Market Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
  • Product Type
Product Types Covered Pharmaceuticals (Small Molecule Drugs), Biopharmaceuticals, Vaccines and Over-The-Counter Drugs
Companies Covered Johnson & Johnson Services, Inc., Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc., Eli Lilly and Company, Novartis International AG, Sanofi S.A, AstraZeneca PLC, F. Hoffmann-La Roche Ltd. (Roche), Bayer AG, Bristol- Myers Squibb (BMS). etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Benefits for Stakeholders:

  • IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the US healthcare advertising market from 2018-2032.
  • The research study provides the latest information on the market drivers, challenges, and opportunities in the US healthcare advertising market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the US healthcare advertising industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Key Questions Answered in This Report

The US healthcare advertising market was valued at US$ 23.5 Billion in 2023.

We expect the US healthcare advertising market to exhibit a CAGR of 4% during 2024-2032.

Various healthcare corporations in the United States are heavily investing on online display advertising, brand websites, and social media campaigns, which are currently driving the US healthcare advertising market.

The sudden outbreak of the COVID-19 pandemic has resulted in the increasing adoption of electronic health records, telemedicines, and remote medical monitoring, thereby positively influencing the market for healthcare advertising in the US.

Based on the product type, the US healthcare advertising market can be bifurcated into pharmaceuticals (small molecule drugs) market, biopharmaceuticals market, vaccines market, and Over-the-Counter (OTC) drugs market. Among these, pharmaceuticals (small molecule drugs) advertising accounts for the majority of the total market share.

Some of the major players in the US healthcare advertising market include Johnson & Johnson, Pfizer, Merck & Co., GlaxoSmithKline, Roche, etc.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
US Healthcare Advertising Market Report by Product Type (Pharmaceuticals (Small Molecule Drugs), Biopharmaceuticals, Vaccines, Over-The-Counter (OTC) Drugs) 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More